Tender Loving Care for Recurrent Pregnancy Loss

Status Not yet recruiting

Clinical Trial Summary

The goal of this investigational study is to evaluate participation in a weekly, interactive, tender loving care messaging platform impact on pregnancy outcomes in patients with recurrent pregnancy loss. The main questions it aims to answer are: (1) does participation in weekly, interactive tender loving care messages increase live birth rates in patients with recurrent pregnancy loss? (2) Does participation in weekly, interactive tender loving care messages increase patients' quality of life? Does participation in weekly, interactive tender loving care messages decrease patients' depressive symptoms? Participants will be asked to interact with weekly messages providing prenatal counseling and support. Additionally, patients will be asked to complete the fertility quality of life survey several times over the course of the pregnancy.

Clinical Trial Description

Participants will be asked to interact with weekly messages providing prenatal counseling and support. Additionally, patients will be asked to complete the fertility quality of life survey several times over the course of the pregnancy. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT06182878
Study type	Interventional
Source	Walter Reed National Military Medical Center
Contact	David Boedeker, DO
Phone	301-400-2140
Email	david.h.boedeker.mil@health.mil
Status	Not yet recruiting
Phase	N/A
Start date	January 1, 2024
Completion date	December 1, 2025

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04718233` - Effect of Sildenafil Citrate on Mid Luteal Phase Uterine Artery Blood Flow in Patients With Recurrent Pregnancy Loss	Phase 2
Recruiting	`NCT01946945` - Comparison of Standard ART Practice vs. Trophectoderm Biopsy and Whole Chromosome Analysis	Phase 2
Completed	`NCT02572154` - Sperm DNA Fragmentation in Recurrent Pregnancy Loss	N/A
Completed	`NCT03174951` - Immunomodulatory Effects of IVIg on Pregnancy Rate of Patient With Recurrent Pregnancy Loss	Phase 2
Recruiting	`NCT05444283` - Genomic Predictors of Recurrent Pregnancy Loss
Active, not recruiting	`NCT04621773` - Live Birth Rate in Patients With Unexplained Recurrent Pregnancy Loss
Recruiting	`NCT02990403` - The Novel Immunomodulatory and Anticoagulant Therapies for Recurrent Pregnancy Loss	Phase 4
Recruiting	`NCT02990390` - The Epidemiology of Recurrent Spontaneous Abortion Associated With Thrombophilla	N/A
Not yet recruiting	`NCT05612620` - Elucidating the Microbiome in Patients With Recurrent Pregnancy Loss
Not yet recruiting	`NCT05520112` - Treatment of Recurrent Pregnancy Loss Using Mesenchymal Stem Cells	Phase 1/Phase 2
Suspended	`NCT04397042` - SCUBE-1 and Carotid Intima Media Thickness in Recurrent Pregnancy Loss
Not yet recruiting	`NCT05341856` - Uterine Artery Doppler Changes After Vaginal Administration of Isosorbide Mononitrate In Patients With URPL	Early Phase 1
Recruiting	`NCT06007560` - Aerobe Cycling Training in Women With Unexplained Recurrent Pregnancy Loss	N/A
Completed	`NCT02386384` - TNFα and MFG-E8: Novel Biomarkers to Predict Implantation Failure	N/A
Recruiting	`NCT01635426` - Aspirin Versus Clopidogrel Effect on Uterine Blood Flow in Women With Unexplained Recurrent Miscarriages	Phase 2/Phase 3
Suspended	`NCT01546350` - Preimplantation Genetic Diagnosis Using Blastocyst Biopsy and Array CGH	Phase 2
Completed	`NCT00721591` - Pharmacokinetics of Low Molecular Weight and Unfractionated Heparin in Pregnancy	N/A
Terminated	`NCT00564174` - Low Molecular Weight Heparin and Aspirin in the Treatment of Recurrent Pregnancy Loss: A RCT	N/A
Completed	`NCT04455256` - Evaluation of Endoplasmic Reticulum Stress in Patients With Recurrent Pregnancy Loss
Not yet recruiting	`NCT05237843` - Hydroxychloroquine in Unexplained Recurrent Pregnancy Loss	Phase 1